68Ga-NODAGA-RGD PET/CT定位甲状旁腺腺瘤并显示「代谢性超级骨显像」伴Lincoln征与肋软骨交界串珠样改变:一种潜在临床应用
本文报道一名12岁原发性甲状旁腺功能亢进症女童,术前使用68Ga-NODAGA-RGD PET/CT进行检查,除定位右侧下甲状旁腺腺瘤外,还显示弥漫性骨骼放射性摄取(超级骨显像),提示全身性效应。作者认为68Ga-RGD PET/CT可能成为甲状旁腺显像和全身评估的工具,值得进一步研究以确定其诊断价值及在治疗反应评估中的作用。
要点
- 68Ga-NODAGA-RGD PET/CT在12岁PHPT女童中定位右侧下甲状旁腺腺瘤。
- 该扫描同时显示弥漫性骨骼放射性摄取(超级骨显像),提示全身性效应。
- 作者认为该显像可能用于甲状旁腺显像和全身评估,值得进一步研究。
核心结论
- 作者认为68Ga-RGD PET/CT可能成为甲状旁腺显像和全身评估的工具,值得进一步研究以确定其诊断价值及在治疗反应评估中的作用。
研究设计与样本
- 本文为病例报告,对象为一名12岁患原发性甲状旁腺功能亢进症的女童,接受68Ga-NODAGA-RGD PET/CT检查。
主要发现
- 68Ga-NODAGA-RGD PET/CT定位右侧下甲状旁腺腺瘤,并显示弥漫性骨骼放射性摄取(超级骨显像),提示全身性效应。
关键数值与推荐
- 原文提及传统影像包括99mTc-Sestamibi闪烁显像、SPECT/CT和4DCT,新型PET示踪剂如18F-氟胆碱和68Ga-Trivehexin显示前景。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In primary hyperparathyroidism (PHPT), exact preoperative localization of parathyroid adenomas is essential for best surgical planning. While new PET tracers like 18 F-fluorocholine and 68 Ga-Trivehexin show promise, traditional imaging consists of 99m Tc-Sestamibi scintigraphy, SPECT/CT, and 4DCT. Herein, we report the potential new application of another angiogenesis imaging agent, 68 Ga-NODAGA-RGD PET/CT, illustrated in a 12-year-old girl with PHPT. The scan revealed diffuse skeletal tracer uptake (superscan) in addition to localizing right inferior parathyroid adenoma, thereby indicating systemic effects. This case underscores 68 Ga-RGD PET/CT as a possible instrument for parathyroid imaging and systemic evaluation, justifying more research to define its diagnostic value and role in treatment response evaluation.
引用
- Verma P, Reddy MM, Lila A, et al. Localization of Parathyroid Adenoma With 68 Ga-NODAGA-RGD PET/CT and Demonstration of "Metabolic Superscan" With Lincoln Sign and Costochondral Junction Beading : A Potential Clinical Application. Clin Nucl Med. 2025. PMID: 40472287. doi:10.1097/RLU.0000000000006013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。